UNICHEM LABORATORIES
Quarterly Results Analysis [Dec2024]
UNICHEM LABORATORIES Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹533 Cr | ₹462 Cr | ₹446 Cr | ₹432 Cr | ₹466 Cr | ₹416 Cr | ₹423 Cr | ₹402 Cr |
Expenses | ₹448 Cr | ₹405 Cr | ₹403 Cr | ₹406 Cr | ₹435 Cr | ₹407 Cr | ₹395 Cr | ₹386 Cr |
Operating Income | ₹86 Cr | ₹58 Cr | ₹43 Cr | ₹25 Cr | ₹31 Cr | ₹9 Cr | ₹28 Cr | ₹16 Cr |
Other Income | ₹14 Cr | ₹9 Cr | ₹4 Cr | ₹6 Cr | ₹11 Cr | ₹6 Cr | ₹9 Cr | ₹5 Cr |
Interest | ₹7 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr |
Depreciation | ₹31 Cr | ₹29 Cr | ₹28 Cr | ₹27 Cr | ₹32 Cr | ₹29 Cr | ₹29 Cr | ₹30 Cr |
Profit Before Tax | ₹62 Cr | ₹33 Cr | ₹15 Cr | ₹-126 Cr | ₹73 Cr | ₹-22 Cr | ₹2 Cr | ₹-47 Cr |
Profit After Tax | ₹58 Cr | ₹30 Cr | ₹9 Cr | ₹-129 Cr | ₹73 Cr | ₹-24 Cr | ₹-1 Cr | ₹-44 Cr |
EPS | ₹8.22 | ₹4.33 | ₹1.31 | ₹-18.37 | ₹10.40 | ₹-3.48 | ₹-0.09 | ₹-6.29 |
Industry Peers & Returns | 1W | 1M | 1Y |
UNICHEM LABORATORIES | -4.8% | -15.9% | -1.9% |
SUN PHARMACEUTICAL INDUSTRIES | -4.9% | 2.1% | 15.5% |
DIVIS LABORATORIES | -2.2% | 9.3% | 50.5% |
CIPLA | -4.2% | 4.5% | 4.5% |
TORRENT PHARMACEUTICALS | -4.4% | -4.5% | 17.2% |
DR REDDYS LABORATORIES | -1.4% | 4.2% | -8.8% |
MANKIND PHARMA | -0.1% | -1.5% | 6.6% |
ZYDUS LIFESCIENCES | -1.6% | 1.3% | -14.6% |
LUPIN | -2.4% | 3.4% | 19.9% |
UNICHEM LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 15.35 % |
Y-o-Y | 14.47 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹533 Cr | 15.35 | |
Sep2024 | ₹462 Cr | 3.52 | |
Jun2024 | ₹446 Cr | 3.41 | |
Mar2024 | ₹432 Cr | -7.30 | |
Dec2023 | ₹466 Cr | 12.05 | |
Sep2023 | ₹416 Cr | -1.79 | |
Jun2023 | ₹423 Cr | 5.24 | |
Mar2023 | ₹402 Cr | - |
UNICHEM LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 48.65 % |
Y-o-Y | 174.81 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹86 Cr | 48.65 | |
Sep2024 | ₹58 Cr | 32.26 | |
Jun2024 | ₹43 Cr | 71.58 | |
Mar2024 | ₹25 Cr | -18.54 | |
Dec2023 | ₹31 Cr | 254.85 | |
Sep2023 | ₹9 Cr | -68.70 | |
Jun2023 | ₹28 Cr | 69.98 | |
Mar2023 | ₹16 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 28.84 % |
Y-o-Y | 140.12 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 16.04% | 28.84 | |
Sep2024 | 12.45% | 27.82 | |
Jun2024 | 9.74% | 65.93 | |
Mar2024 | 5.87% | -12.13 | |
Dec2023 | 6.68% | 216.59 | |
Sep2023 | 2.11% | -68.13 | |
Jun2023 | 6.62% | 61.46 | |
Mar2023 | 4.1% | - |
UNICHEM LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 89.73 % |
Y-o-Y | -20.99 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹58 Cr | 89.73 | |
Sep2024 | ₹30 Cr | 229.44 | |
Jun2024 | ₹9 Cr | Positive | |
Mar2024 | ₹-129 Cr | Negative | |
Dec2023 | ₹73 Cr | Positive | |
Sep2023 | ₹-24 Cr | Negative | |
Jun2023 | ₹-1 Cr | Negative | |
Mar2023 | ₹-44 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 64.39 % |
Y-o-Y | -30.98 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 10.85 % | 64.39 | |
Sep2024 | 6.6 % | 218.84 | |
Jun2024 | 2.07 % | Positive | |
Mar2024 | -29.95 % | Negative | |
Dec2023 | 15.72 % | Positive | |
Sep2023 | -5.89 % | Negative | |
Jun2023 | -0.16 % | Negative | |
Mar2023 | -11.01 % | - |
UNICHEM LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 89.84 % |
Y-o-Y | -20.96 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹8.22 | 89.84 | |
Sep2024 | ₹4.33 | 230.53 | |
Jun2024 | ₹1.31 | Positive | |
Mar2024 | ₹-18.37 | Negative | |
Dec2023 | ₹10.4 | Positive | |
Sep2023 | ₹-3.48 | Negative | |
Jun2023 | ₹-0.09 | Negative | |
Mar2023 | ₹-6.29 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD